NIH Director Dr. Jay Bhattacharya Testifies on FY 2026 Budget
Jayanta Bhattacharya, M.D., Ph.D., Director of the National Institutes of Health
(NIH), appeared before the Senate Committee on Appropriations
on June 10. Dr. Bhattacharya,
in his prepared statement, stated that NIH’s fiscal year (FY) 2026
budget request of $27 billion would help the NIH find “better ways to prevent,
treat, and cure chronic diseases.” He also noted that “Research has shown
that chronic disease in later life is influenced by exposure to various risk factors during childhood.
Biologic, social, and environmental drivers of health each contribute to a person’s
risk for disease development.” Additionally, he addressed academic freedom,
artificial intelligence and data sharing in his opening statement.
During questioning, U.S. Sen. Tammy Baldwin (D-WI), the Labor-Health & Human
Services-Education and Related Agencies Subcommittee Ranking Member, criticized
the cancelling of 4,000 grants and $4.9 billion in grants since January and expressed
concern that it was motivated by political interests, not science.
In addition,
U.S. Sen. Susan Collins (R-ME), Appropriations Committee Chair, criticized the
15% cap on indirect costs as “poorly conceived” and a violation of appropriations
law, that expressly prohibits such action.
Dr. Bhattacharya defended the Trump
administration’s actions in each instance.
Other members raised questions regarding Alzheimer’s disease, cancer, and opioid addiction research.
U.S. Sen. Richard Durbin (D-IL) noted that former Director Dr.
Francis Collins
advocated for 5% real growth in biomedical research each year to maintain U.S. global leadership in that area.
Durbin noted that the NIH FY 2026 budget wipes out the progress made in the last several years toward that goal.